A settlement has been reached between fertility technology company CooperSurgical and couples who alleged that defects in the company’s recalled IVF culture media contributed to embryo loss during fertility treatment. CooperSurgical’s recalled IVF culture media was reportedly used in fertility clinics across more than 30 states and 20 countries. According to recall notices and subsequent lawsuits, reported “performance issues” with the product were associated with impaired embryo development during some IVF procedures.
CooperSurgical’s Recalled IVF Culture Media
CooperSurgical is a fertility technology company that provides products and services used in assisted reproductive treatments. The company faced significant scrutiny in late 2023, after its IVF culture media was recalled due to “performance issues [that] may lead to impaired embryo development prior to the blastocyst stage.” Culture media is a crucial component of the in vitro fertilization (IVF) process, as it is designed to support the development of human embryos outside the body until implantation. Reports indicated that certain recalled lots of CooperSurgical’s IVF culture media may have lacked magnesium, a component important to embryo development. Plaintiffs alleged that the issue contributed to impaired embryo growth and embryo loss during fertility treatment.
The IVF Solution Recall Announcement
On December 20, 2023, CooperSurgical issued a recall for specific lots of its LifeGlobal IVF culture media after receiving numerous complaints about its performance. In an Urgent Medical Device Recall Field Safety Notice, the company stated that the affected product could potentially impair embryo development prior to the blastocyst stage. This announcement prompted immediate concern among fertility clinics and patients alike, as the implications of using a defective IVF solution became apparent.
CooperSurgical Embryo Loss Lawsuits
As a result of the IVF culture media recall, numerous product liability lawsuits were filed against CooperSurgical by couples who experienced embryo loss. The complaints included allegations that CooperSurgical failed to adequately test the product and failed to provide sufficient warnings regarding potential risks associated with its use. The CooperSurgical lawsuits also alleged that embryo loss resulted in significant emotional and financial hardship for affected families, many of whom had invested substantial time and resources in fertility treatment.
Defective IVF Solution Settlement Agreement
On May 5, 2026, an Order of Dismissal Upon Settlement notice was filed in the U.S. District Court for the Northern District of California, indicating that the parties involved in the class action lawsuit related to the LifeGlobal IVF culture media recall had filed a notice of settlement. While specific terms of the CooperSurgical settlement have not been publicly disclosed, the agreement resolves the litigation, subject to finalization of the settlement terms. U.S. District Judge Jon S. Tigar oversaw the dismissal order, indicating that the lawsuit could be reinstated if the settlement is not finalized within 90 days.
Impact of Embryo Loss on Affected Families
The embryo loss allegations at the center of the CooperSurgical litigation have drawn attention to the emotional and financial challenges associated with fertility treatment. For many individuals and couples undergoing IVF, embryos represent a significant investment of time, resources, and hope for future family-building. According to court filings and public reports, some families affected by the recalled culture media reported experiencing emotional distress following unsuccessful embryo development and treatment setbacks.
IVF treatment often involves multiple medical procedures and can require substantial financial commitments. In addition to the costs of fertility care, some affected families have incurred expenses related to pursuing legal claims connected to the recall. The IVF solution litigation has also highlighted broader concerns about the potential impact that product-related issues can have on patients undergoing fertility treatment. For affected families, the reported embryo losses represented not only a financial setback but also a disruption to ongoing reproductive plans.
Broader Questions for the Fertility Industry
The CooperSurgical lawsuit and settlement has drawn attention to the products and materials used during the IVF process. The litigation also highlights the role that manufacturers, fertility clinics, and regulators play in maintaining quality standards for reproductive medicine products.
IVF Product Safety and Regulatory Review
The CooperSurgical recall prompted renewed discussion about quality control procedures and oversight of products used in assisted reproductive technologies. While fertility treatments rely on a range of specialized medical products, recalls involving these materials can have far-reaching consequences for clinics and patients alike. As demand for IVF and other fertility services continues to grow, product safety and manufacturing standards remain important areas of focus.
Although the CooperSurgical settlement effectively resolves the litigation, the long-term effects of the recall may continue to be felt throughout the fertility industry. Manufacturers and healthcare providers may evaluate existing quality assurance practices, while patients and clinics may pay closer attention to product sourcing, testing, and safety protocols. Any future changes resulting from the litigation will likely emerge over time as the industry responds to lessons learned from the recall.
Settlement Brings Recalled IVF Solution Lawsuit to a Close
The settlement with CooperSurgical marks a significant development in the litigation stemming from the 2023 LifeGlobal IVF culture media recall. While the settlement terms have not been publicly disclosed, the agreement represents the latest step in resolving legal claims brought by individuals who alleged embryo loss related to the recalled product. The settlement also serves as a reminder of the complex medical, regulatory, and legal issues that can arise when concerns are raised about products used in fertility treatment.
CooperSurgical IVF Solution Lawsuit Information
Coopersurgical IVF Solution Recall, Leading Justice
Class 2 Device Recall global Medium, FDA
